Physician profile
Christopher Anthony Marinakis
NPI 1952401895
$1,927.96
in general payments reported to CMS, 2019-2025
20 companies · $368 in 2025
The $368 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $783 · 2020: $451 · 2022: $146 · 2023: $41.90 · 2024: $138 · 2025: $368.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $495 · Travel and Lodging: $52.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $495.37 |
| Travel and Lodging | $52.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $667.96 | 2022-2025 | Interstim, Altaviva |
| Medtronic USA, INC. | $392.61 | 2019-2020 | |
| Astellas Pharma US INC | $177.47 | 2019 | |
| Neotract INC. | $171.62 | 2019-2020 | |
| Amgen INC. | $73.28 | 2019 | |
| Pfizer INC. | $66.92 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $53.30 | 2019 | |
| Coloplast Corp | $44.32 | 2019 | |
| Boston Scientific Corporation | $43.60 | 2019 | |
| Dornier Medtech America, INC | $43.30 | 2019 | |
| Antares Pharma, INC. | $33.54 | 2019 | |
| Abbvie INC. | $30.83 | 2019 | |
| Becton, Dickinson and Company | $25.66 | 2023 | |
| C. R. Bard, INC. & Subsidiaries | $24.33 | 2019 | |
| Janssen Biotech, INC. | $15.60 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rgh Enterprises LLC | $14.43 | 2019 | |
| Travere Therapeutics, INC. | $12.95 | 2019 | |
| Allergan, INC. | $12.77 | 2019 | |
| Endo Pharmaceuticals INC. | $12.50 | 2019 | |
| Olympus America INC. | $10.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Marinakis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.